Related Experiment Video
Updated: Jun 27, 2026
06:28
E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Patterns and changes in prescriber attitudes toward PDA prescription-assistive technology
Arun Vishwanath1, Linda Brodsky, Steve Shaha
1Department of Communication, State University of New York at Buffalo, 333 Lord Christopher Baldy Hall, Buffalo, NY 14260, USA. avishy@buffalo.edu
International Journal of Medical Informatics
|December 20, 2008
Summary
Introducing personal digital assistants (PDAs) for medication prescribing improved attitudes among clinicians initially hesitant towards technology. Understanding prescriber adoption patterns is key for successful technology implementation in healthcare.
Area of Science:
- Healthcare Technology Adoption
- Medical Informatics
- Clinical Decision Support Systems
Background:
- Medication error prevention is a critical healthcare priority.
- Technology adoption in healthcare faces attitudinal barriers.
- Limited knowledge exists regarding clinician attitudes towards health technologies.
Purpose of the Study:
- To assess frontline prescriber clinicians' attitudes towards technology and PDAs.
- To evaluate these attitudes before and after PDA implementation for medication prescribing.
Main Methods:
- A pre- and post-intervention web-based survey was conducted 12-14 months apart.
- 244 prescriber clinicians participated at an academic tertiary care children's hospital.
- Participants received a PDA with pediatric medication information post-training.
Main Results:
- Clinicians were categorized as Early Adopters (favorable to technology) and Late Adopters.
- Early Adopters showed consistently more favorable attitudes and higher PDA usage.
- PDA use was driven by ease of use for Early Adopters and clinical usefulness for Late Adopters.
Conclusions:
- PDA implementation did not alter attitudes of those already favorable to technology.
- A significant positive attitude shift occurred in initially less favorable clinicians.
- Understanding adopter types and tailoring interventions are crucial for successful technology integration.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:19Standards of Care II
Nurses bear specific legal responsibilities under several federal statutes, including:
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...